Trulign toric accommodating posterior chamber iol
Topical postoperative medications included ofloxacin 0.3% QID, prednisolone acetate 1% QID and bromfenac 0.09% QD.
Over-the-counter lubricants and Muro 128 solution (Bausch Lomb) were also prescribed for the early postoperative period.
The patient had a history of endothelial dystrophy and had already undergone DSEK in the fellow eye five months prior. The patient’s visual acuity on day one was limited to hand motion OD.
The endothelial graft was well centered and the cornea showed 1 to 2 stromal edema, as expected. Anterior bowing of the iris was visible 360° with an occluded angle, despite a patent prophylactic peripheral iridectomy inferiorly.
surgeons have been able to correct either astigmatism or presbyopia with intraocular lenses, but not both.
In this article, surgeons who’ve worked with the Trulign lens share their experiences and tips for getting the best outcomes while avoiding complications.
Careful preoperative evaluation and sound clinical judgement should be used by the surgeon to decide the risk / benefit ration before implanting a lens in a patient.
This is not an indication of a security issue such as a virus or attack.
Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the benefit/risk ratio before implanting a lens in a patient with conditions as outlined in the AO IOL Directions for Use.
The incidence of adverse events experienced during the clinical trial was comparable to or lower than the incidence reported in the historic control (“FDA grid”) population. Vaulting is a post-operative adverse event where the AO IOL optic hinges move into and remain in a displaced configuration.
The Trulign, like the standard Crystalens, is a silicone lens with a 5-mm optic and flexible, rectangular hinged haptics with polyamide loops.
It’s available in 4 to 10 D spherical equivalent powers (in 1-D increments) and 10.5 to 33 D powers (in 0.5-D increments).